Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes
{{output}}
Over 10% of small-cell lung cancer (SCLC) patients have brain metastases (BM) at initial diagnosis; more than 50% will develop BM within 2 years. BM are detected in up to 80% of all patients at autopsy. After primary treatment, prophylactic cranial irradiation... ...
